Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for ANDA 090899

Expand all

VENLAFAXINE HYDROCHLORIDE (VENLAFAXINE HYDROCHLORIDE)
EQ 37.5MG BASE
Marketing Status: Discontinued

Active Ingredient: VENLAFAXINE HYDROCHLORIDE
Proprietary Name: VENLAFAXINE HYDROCHLORIDE
Dosage Form; Route of Administration: CAPSULE, EXTENDED RELEASE; ORAL
Strength: EQ 37.5MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: A090899
Product Number: 001
Approval Date: Jun 1, 2011
Applicant Holder Full Name: TORRENT PHARMACEUTICALS LTD
Marketing Status:  Discontinued
Patent and Exclusivity Information

VENLAFAXINE HYDROCHLORIDE (VENLAFAXINE HYDROCHLORIDE)
EQ 75MG BASE
Marketing Status: Discontinued

Active Ingredient: VENLAFAXINE HYDROCHLORIDE
Proprietary Name: VENLAFAXINE HYDROCHLORIDE
Dosage Form; Route of Administration: CAPSULE, EXTENDED RELEASE; ORAL
Strength: EQ 75MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: A090899
Product Number: 002
Approval Date: Jun 1, 2011
Applicant Holder Full Name: TORRENT PHARMACEUTICALS LTD
Marketing Status:  Discontinued
Patent and Exclusivity Information

VENLAFAXINE HYDROCHLORIDE (VENLAFAXINE HYDROCHLORIDE)
EQ 150MG BASE
Marketing Status: Discontinued

Active Ingredient: VENLAFAXINE HYDROCHLORIDE
Proprietary Name: VENLAFAXINE HYDROCHLORIDE
Dosage Form; Route of Administration: CAPSULE, EXTENDED RELEASE; ORAL
Strength: EQ 150MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: A090899
Product Number: 003
Approval Date: Jun 1, 2011
Applicant Holder Full Name: TORRENT PHARMACEUTICALS LTD
Marketing Status:  Discontinued
Patent and Exclusivity Information